Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

337.02

-6.32 (-1.84%)

Aug 20, 2026, 4:00 PM EDT - Market closed

Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	427.74	496.3	344.87	358.33	161.9	341.25
Short-Term Investments	417.89	331.49	252.65	173.85	217.27	96.85
Cash & Short-Term Investments	845.63	827.79	597.52	532.18	379.17	438.1
Cash Growth	24.00%	38.54%	12.28%	40.35%	-13.45%	61.50%
Receivables	138.66	127.43	104.75	42.04	-	-
Inventory	45.56	40.48	26.51	6.99	-	-
Prepaid Expenses	29.8	28.91	13.27	6.71	4.61	4.17
Total Current Assets	1,060	1,025	742.05	587.91	383.78	442.27
Property, Plant & Equipment	160.6	158.02	161.45	168.23	169.73	119.58
Long-Term Investments	257.29	128.07	152.11	61.95	4.62	64.37
Long-Term Deferred Tax Assets	22.82	22.82	-	-	-	-
Other Long-Term Assets	0.28	0.29	0.23	0.26	0.32	0.07
Total Assets	1,501	1,334	1,056	818.36	558.45	626.3

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.54	3.24	4.99	4.13	3.98	8.4
Accrued Expenses	100.67	81.25	52.78	18.15	11.54	6.52
Current Portion of Leases	1.81	1.77	1.22	1.47	1.56	1.04
Current Income Taxes Payable	14.81	10.92	4.29	1.96	0.04	0.08
Other Current Liabilities	3.57	5.77	38.73	7.38	11.72	9.69
Total Current Liabilities	127.4	102.94	102	33.09	28.85	25.74
Long-Term Leases	7.05	7.57	6.04	6.62	7.37	6.98
Other Long-Term Liabilities	7.08	3.72	1.42	-	-	-
Total Liabilities	141.52	114.23	109.46	39.71	36.22	32.72

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	1,229	1,194	1,127	1,048	803.72	734.52
Retained Earnings	134.86	24.16	-180.67	-269.83	-280.76	-140.78
Comprehensive Income & Other	-4.34	1.14	-0.19	0.64	-0.73	-0.16
Total Common Equity	1,359	1,220	946.38	778.64	522.23	593.58
Shareholders' Equity	1,359	1,220	946.38	778.64	522.23	593.58
Total Liabilities & Equity	1,501	1,334	1,056	818.36	558.45	626.3

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	8.85	9.34	7.26	8.09	8.93	8.02
Net Cash (Debt)	1,094	946.52	742.37	586.04	374.86	494.44
Net Cash Growth	34.88%	27.50%	26.68%	56.34%	-24.19%	84.97%
Net Cash Per Share	36.07	31.60	24.96	21.12	14.70	22.28
Filing Date Shares Outstanding	29.6	29.23	28.81	28.29	25.76	25.21
Total Common Shares Outstanding	29.6	29.19	28.79	28.24	25.76	25.21
Working Capital	932.25	921.66	640.05	554.82	354.93	416.53
Book Value Per Share	45.92	41.78	32.87	27.58	20.27	23.55
Tangible Book Value	1,359	1,220	946.38	778.64	522.23	593.58
Tangible Book Value Per Share	45.92	41.78	32.87	27.58	20.27	23.55
Buildings	109.41	109.24	111.44	111.18	-	-
Machinery	39.55	37.48	34.19	30.49	12.93	6.51
Construction In Progress	9.53	8.11	5.78	7.29	131.33	104.34
Leasehold Improvements	31.66	27.23	25.67	25.07	24.22	5.72

SEC Filings: 10-K · 10-Q